Subscribe to our Newsletters !!
The safety and quality of produced medicines is ex
The use of the Greek letter sigma (Σ, σ) extends
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-look
Russia begins Phase III trials of a second possible vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer security watchdog Rospotrebnadzor as saying on October 2.
Early-stage clinical trials for the vaccine have been completed on Wednesday.
